First-trimester exposure to ACE inhibitors is associated with congenital malformations

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Nephrology | 2006年 / 2卷 / 10期
关键词：
D O I：
10.1038/ncpneph0256
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
下载
收藏
页码：544 / 544
相关论文
共 50 条
  • [1] First-trimester exposure to ACE inhibitors is associated with congenital malformations
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (10): : 529 - 529
  • [2] Major congenital malformations after first-trimester exposure to ACE inhibitors
    Cooper, William O.
    Hernandez-Diaz, Sonia
    Arbogast, Patrick G.
    Dudley, Judith A.
    Dyer, Shannon
    Gideon, Patricia S.
    Hall, Kathi
    Ray, Wayne A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23): : 2443 - 2451
  • [3] First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations
    Damkier, Per
    Broe, Anne
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (04): : 374 - 376
  • [4] Major congenital malformations after first-trimester exposure to ACE inhibitors. Results of the epidemiological study based on Tennessee medicaid data
    Lyakishev, A. A.
    KARDIOLOGIYA, 2006, 46 (09) : 75 - 75
  • [5] First-trimester exposure to antiepileptic medications is an independent risk factor for major congenital malformations
    Koren, Gideon
    Levy, Amalia
    Matok, Ilan
    Brosh, Koby
    Sheiner, Eyal
    Wiznitzer, Arnon
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S296 - S296
  • [6] ACE Inhibitors During the First Trimester of Pregnancy and the Risk of Congenital Malformations: A Cohort Study
    Bateman, Brian T.
    Hernandez-Diaz, Sonia
    Patorno, Elisabetta
    Desai, Rishi
    Huybrechts, Krista F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 400 - 401
  • [7] Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan
    Ishikawa, Tomofumi
    Obara, Taku
    Akazawa, Manabu
    Noda, Aoi
    Oyanagi, Gen
    Morishita, Kei
    Miyakoda, Keiko
    Nishigori, Hidekazu
    Kawame, Hiroshi
    Yaegashi, Nobuo
    Kuriyama, Shinichi
    Mano, Nariyasu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (02) : 196 - 205
  • [8] First-trimester exposure to bupropion and risk of cardiac malformations
    Louik, Carol
    Kerr, Stephen
    Mitchell, Allen A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (10) : 1066 - 1075
  • [9] First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review
    Lassen, Dorte
    Ennis, Zandra Nymand
    Damkier, Per
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (01) : 32 - 36
  • [10] Congenital anomalies following first-trimester metformin exposure
    Reactions Weekly, 2018, 1709 (1) : 6 - 6
12345